Cargando…

The erythropoietin neuroprotective effect: assessment in coronary artery bypass graft surgery (TENPEAKS) – a randomized, double-blind, placebo-controlled, proof-of-concept clinical trial

Detalles Bibliográficos
Autores principales:	Haljan, G, Maitland, A, Buchan, A, King, M, Haigh, J, Culleton, B, Faris, P, Zygun, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092602/ http://dx.doi.org/10.1186/cc4574

Ejemplares similares

Magnetically guided targeted delivery of erythropoietin using magnetic nanoparticles: Proof of concept
por: Nguyen, Chanh Trung, et al.
Publicado: (2020)

Erythropoietin protection effects against ischemia-reperfusion injuries during coronary artery bypass graft surgery: a randomized, double blinded, placebo control study
por: Ziabakhsh Tabary, SH, et al.
Publicado: (2013)

Nonhematopoietic Variants of Erythropoietin in Ischemic Stroke: Need for Step-Wise Proof-of-Concept Studies
por: Hermann, Dirk M.
Publicado: (2010)

Erythropoietin: a multimodal neuroprotective agent
por: Byts, Nadiya, et al.
Publicado: (2009)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
por: Hernández, Carolina Castillo, et al.
Publicado: (2017)

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer’s disease
por: Cummings, Jeffrey L., et al.
Publicado: (2016)

Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke
por: Asadi, Bahador, et al.
Publicado: (2013)

Echocardiographic evaluation of a single bolus of erythropoietin effects on reducing ischemia-reperfusion injuries during coronary artery bypass graft surgery. A randomized, double blinded placebo control study
por: Ziabakhsh Tabary, SH, et al.
Publicado: (2013)

Echocardiographic Evaluation of the Effects of a Single Bolus of Erythropoietin on Reducing Ischemia-Reperfusion Injuries during Coronary Artery Bypass Graft Surgery; A Randomized, Double-Blind, Placebo-Control Study
por: Ziabakhsh-Tabary, Shervin, et al.
Publicado: (2014)

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2011)

Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection
por: Chen, Jianmin, et al.
Publicado: (2016)

Neuroprotective effects of erythropoietin on rat retinas subjected to oligemia
por: de Carvalho, Litia Alves, et al.
Publicado: (2018)

Neuroprotective mechanisms of erythropoietin in a rat stroke model
por: Juenemann, Martin, et al.
Publicado: (2020)

The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage
por: Yoo, Seung-Jun, et al.
Publicado: (2017)

Erythropoietin Improves Long-Term Outcomes in Patients with Acute Kidney Injury after Coronary Artery Bypass Grafting
por: Oh, Se Won, et al.
Publicado: (2012)

Neuroprotective potential of erythropoietin in neonates; design of a randomized trial
por: Juul, Sandra E., et al.
Publicado: (2015)

Correction to: “Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection”
por: Chen, Jianmin, et al.
Publicado: (2016)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
por: Rey, Federica, et al.
Publicado: (2021)

Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
por: Cho, Bongki, et al.
Publicado: (2021)

A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
por: Toniolo, Ricardo Alexandre, et al.
Publicado: (2017)

Mechanical Signals Inhibit Growth of a Grafted Tumor In Vivo: Proof of Concept
por: Brossel, Rémy, et al.
Publicado: (2016)

Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
por: Koblan, Kenneth S, et al.
Publicado: (2015)

Relieving acute pain (RAP) study: a proof-of-concept protocol for a randomised, double-blind, placebo-controlled trial
por: Colloca, Luana, et al.
Publicado: (2019)

Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
por: Arnold, Leslie M, et al.
Publicado: (2020)

Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Outpatient Treatment of Mild Coronavirus Disease (COVID-19)
por: McCreary, Marvin R., et al.
Publicado: (2021)

An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
por: Sen, Arjune, et al.
Publicado: (2021)

Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)
por: McCreary, Marvin R., et al.
Publicado: (2022)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
por: Moransard, M., et al.
Publicado: (2017)

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
por: Kaddurah-Daouk, R, et al.
Publicado: (2011)

Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients
por: Cramer, Steven C., et al.
Publicado: (2017)

Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial
por: Altay, Halit Yusuf, et al.
Publicado: (2022)

Actissist: Proof-of-Concept Trial of a Theory-Driven Digital Intervention for Psychosis
por: Bucci, Sandra, et al.
Publicado: (2018)

Erythropoietin; a review on current knowledge and new concepts
por: Tamadon, Mohamad-Reza, et al.
Publicado: (2013)

Effects of Iron Sucrose and Erythropoietin on Transfusion Requirements in Patients with Preoperative Iron Deficiency Anemia Undergoing on-Pump Coronary Artery Bypass Graft
por: Jafari, Shima, et al.
Publicado: (2022)

Saphenous Vein Graft Disease and Serum Erythropoietin Level
por: Joob, Beuy, et al.
Publicado: (2016)

Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2013)

A Phase 2 Proof‐of‐Concept, Randomized, Placebo‐Controlled Trial of CX‐8998 in Essential Tremor
por: Papapetropoulos, Spyros, et al.
Publicado: (2021)

Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
por: Kahaly, George J, et al.
Publicado: (2023)

Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases
por: Rey, Federica, et al.
Publicado: (2019)

Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update
por: Fischer, Hendrik S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jhahfhqdjtabk4f7dn34m341ar